(Q52041500)

20 April 2018

title

HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. (English)

1 reference

20 April 2018

author name string

René J Duquesnoy

series ordinal

1

1 reference

20 April 2018

publication date

1 May 2002

1 reference

20 April 2018

published in

Human Immunology

1 reference

20 April 2018

volume

63

1 reference

20 April 2018

page(s)

339-352

1 reference

20 April 2018

issue

5

1 reference

20 April 2018

Prediction of crossmatch outcome in highly sensitized dialysis patients based on the identification of serum HLA antibodies

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

The definition of HLA specificities by cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Variations of the lymphocytotoxicity test. An evaluation of sensitivity and specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Detection of alloantibodies using a sensitive antiglobulin microcytotoxicity test: identification of low levels of pre-formed antibodies in accelerated allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

HLA alloantibodies and the mechanism of the antiglobulin-augmented lymphocytotoxicity procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Enzyme-linked immunoassay for anti-HLA antibodies--an alternative to panel studies by lymphocytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Detection of panel-reactive anti-HLA class I antibodies by enzyme-linked immunosorbent assay or lymphocytotoxicity. Results of a blinded, controlled multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Evaluation of HLA antibodies with the PRA-STAT test. An ELISA test using soluble HLA class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Detection of alloantibodies by flow cytometry: relevance to clinical transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Detection of HLA class I- and class II-specific antibodies by flow cytometry and PRA-STAT screening in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

New approaches to donor crossmatching and successful transplantation of highly sensitized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

The effect of HLA-A, -B matching on cadaver renal allograft rejection comparing public and private specificities

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Multiscreen serum analysis of highly sensitized renal dialysis patients for antibodies toward public and private class I HLA determinants. Implications for computer-predicted acceptable and unacceptable donor mismatches in kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Epitope specificity of HLA class I alloantibodies: II. Stability of cross-reactive group antibody patterns over extended time periods

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Determination of HLA-A,B residue mismatch acceptability for kidneys transplanted into highly sensitized patients: a report of a collaborative study conducted during the 12th International Histocompatibility Workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Immunoadsorption of anti-HLA antibodies for highly sensitized patients awaiting renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Hyperimmunized patients do not need to wait for an HLA identical donor

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Epitope map of the HLA-B7 CREG using affinity-purified human alloantibody probes

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Topographic map of the HLA-A2 CREG epitopes using human alloantibody probes

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Serological mapping of HLA-epitopes with monoclonal antibodies and its interpretation by sequenced HLA-molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

HLA-B15: a widespread and diverse family of HLA-B alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

HLA-B67: a member of the HLA-B16 family that expresses the ME1 epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Structural diversity in the HLA-A10 family of alleles: correlations with serology

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

HLA-B*0702 antibody epitopes are affected indirectly by distant antigen residues

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Mutagenesis around residue 176 on HLA-B∗0702 characterizes multiple distinct epitopes for anti-HLA antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

The origins of HLA-A,B,C polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

The HLA-B73 antigen has a most unusual structure that defines a second lineage of HLA-B alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Structure of the human class I histocompatibility antigen, HLA-A2

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I alpha 3 domain: CD8 and the T-cell receptor recognize the same class I molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Allo-antibodies to an antigenic determinant shared by HLA-A2 and B17

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

HLA-A2 epitopes recognized by alloantibodies from broadly sensitized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Antigenicity of HLA-A2 and HLA-B7. Loss and gain of serologic determinants induced by site-specific mutagenesis at residues 62 to 80

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Quantitative estimation of HLA-A and HLA-B antigens carrying the Bw4 supertypic specificity in human peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Attempts to locate residues in complementarity-determining regions of antibody combining sites that make contact with antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Epitopes on protein antigens: misconceptions and realities.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

A priori delineation of a peptide which mimics a discontinuous antigenic determinant

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Antigenic cross-reactivity potential of synthetic peptides immobilized on polyethylene rods

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

HLA-DR alpha chain residues located on the outer loops are involved in nonpolymorphic and polymorphic antibody-binding epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Benefits of HLA-CREG matching for sensitized recipients as illustrated in kidney regrafts

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

CREG matching for first kidney transplants performed by SEOPF Centers between October 1987 and September 1995: an analysis of outcome and prospective benefit. Southeastern Procurement Foundation.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

HLA and cross-reactive antigen group matching for cadaver kidney allocation

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

Anti-HLA antibodies after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900382-8

7 January 2021

10.1016/S0198-8859(02)00382-8

Identifiers

DOI

1 reference

20 April 2018

PubMed ID

11975978

1 reference

20 April 2018